{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T08:03:22Z","timestamp":1776931402109,"version":"3.51.2"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To evaluate the role of repeated intravitreal methotrexate as an adjunct to pars plana vitrectomy in the management of rhegmatogenous retinal detachment with choroidal detachment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method:<\/jats:title>\n            <jats:p>The authors compared anatomical and visual outcomes of rhegmatogenous retinal detachment with choroidal detachment eyes that underwent pars plana vitrectomy with (Group B) or without repeated intravitreal methotrexate (Group A).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The study included 25 eyes of 25 patients, 16 eyes in Group A and nine in Group B. Both groups had similar baseline characteristics. In Group A, successful retinal attachment was achieved in 50% as compared with 89% in Group B; however, the difference was not statistically significant (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.08). Also, Group B had a significantly greater change in visual acuity from baseline to the last follow-up visit (1.6 + 1.5 logMAR units) compared with Group A (1.18 + 1 logMAR units) (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.05). There were no significant safety concerns with the use of intravitreal methotrexate.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Repeated intravitreal methotrexate after vitrectomy for rhegmatogenous retinal detachment with choroidal detachment improves outcomes without posing major safety concerns. Nonetheless, further investigation is necessary to establish the optimal intravitreal methotrexate dosage and duration to prevent recurrence effectively.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000004046","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T22:08:36Z","timestamp":1704838116000},"page":"774-781","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["THE ROLE OF INTRAVITREAL METHOTREXATE AS AN ADJUNCT TO LOCAL OR SYSTEMIC CORTICOSTEROIDS IN VITRECTOMY FOR RHEGMATOGENOUS RETINAL DETACHMENT AND CHOROIDAL DETACHMENT"],"prefix":"10.1097","volume":"44","author":[{"given":"Annu","family":"Chahar","sequence":"first","affiliation":[{"name":"Department of Vitreo-Retina and Uvea, Sadguru Netra Chikitsalaya, Chitrakoot, India;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alok","family":"Sen","sequence":"additional","affiliation":[{"name":"Department of Vitreo-Retina and Uvea, Sadguru Netra Chikitsalaya, Chitrakoot, India;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhananjay","family":"Shukla","sequence":"additional","affiliation":[{"name":"Department of Retinal and Vitreous, Ratan Jyoti Eye Hospital, Gwalior, India; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh","family":"Talwar","sequence":"additional","affiliation":[{"name":"Department of Retina and Vitreous, Indraprastha Apollo Hospital, New Delhi, India."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250605","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12886-016-0319-9","article-title":"Risk factors for choroidal detachment following rhegmatogenous retinal detachment in a Chinese population","volume":"16","author":"Yu","year":"2016","journal-title":"BMC Ophthalmol"},{"key":"R2-20250605","first-page":"989","article-title":"Risk factors of rhegmatogenous retinal detachment associated with choroidal detachment in Chinese patients","volume":"9","author":"Gu","year":"2016","journal-title":"Int J Ophthalmol"},{"key":"R3-20250605","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/IAE.0000000000003770","article-title":"Combined rhegmatogenous retinal and choroidal detachment - a systematic review","volume":"43","author":"Tsui","year":"2023","journal-title":"Retina"},{"key":"R4-20250605","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/02713683.2018.1540705","article-title":"Anatomic outcomes and prognostic factors of vitrectomy in patients with primary rhegmatogenous retinal detachment associated with choroidal detachment","volume":"44","author":"Yu","year":"2019","journal-title":"Curr Eye Res"},{"key":"R5-20250605","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/bjo.2007.129437","article-title":"Surgical outcomes for primary rhegmatogenous retinal detachments in phakic and pseudophakic patients: the Retina 1 Project\u2014report 2","volume":"92","author":"Pastor","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R6-20250605","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00006982-200502000-00006","article-title":"Primary vitrectomy for combined rhegmatogenous retinal detachment and choroidal detachment with or without oral corticosteroids: a pilot study","volume":"25","author":"Sharma","year":"2005","journal-title":"Retina"},{"key":"R7-20250605","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1097\/IAE.0b013e3182561f7c","article-title":"Quantitative analysis of rhegmatogenous retinal detachment associated with choroidal detachment in Chinese using UBM","volume":"32","author":"Li","year":"2012","journal-title":"Retina"},{"key":"R8-20250605","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.ophtha.2014.03.012","article-title":"Clinical variables associated with failure of retinal detachment repair: the European vitreo-retinal society retinal detachment study report number 4","volume":"121","author":"Adelman","year":"2014","journal-title":"Ophthalmology"},{"key":"R9-20250605","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00006982-199701000-00009","article-title":"Therapeutic effect of periocular corticosteroids in experimental proliferative vitreoretinopathy","volume":"17","author":"Rubsamen","year":"1997","journal-title":"Retina"},{"key":"R10-20250605","doi-asserted-by":"crossref","first-page":"6707239","DOI":"10.1155\/2020\/6707239","article-title":"Preoperative steroid use in rhegmatogenous retinal detachment associated with choroidal detachment after 23-gauge vitrectomy","volume":"2020","author":"Wu","year":"2020","journal-title":"J Ophthalmol"},{"key":"R11-20250605","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1159\/000529451","article-title":"Steroid drugs as an adjunct for reducing the incidence of proliferative vitreoretinopathy after rhegmatogenous retinal detachment surgery: a meta-analysis of randomized controlled studies","volume":"66","author":"Xu","year":"2023","journal-title":"Ophthalmic Res"},{"key":"R12-20250605","doi-asserted-by":"crossref","first-page":"790460","DOI":"10.3389\/fmed.2021.790460","article-title":"Combined 5-fluorouracil and low molecular weight Heparin for the prevention of postoperative proliferative vitreoretinopathy in patients with retinal detachment: a meta-analysis","volume":"8","author":"Chen","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R13-20250605","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/IAE.0b013e3181754231","article-title":"The safety of intraocular methotrexate in silicone-filled eyes","volume":"28","author":"Hardwig","year":"2008","journal-title":"Retina"},{"key":"R14-20250605","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/09273948.2019.1597894","article-title":"Intra-silicone oil injection of methotrexate in retinal reattachment surgery for proliferative vitreoretinopathy","volume":"28","author":"Falavarjani","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"R15-20250605","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000500271","article-title":"Repeated injection of methotrexate into silicone oil-filled eyes for grade C proliferative vitreoretinopathy: a pilot study","volume":"242","author":"Nourinia","year":"2019","journal-title":"Ophthalmologica"},{"key":"R16-20250605","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.2147\/OPTH.S111893","article-title":"Intravitreal methotrexate infusion for proliferative vitreoretinopathy","volume":"10","author":"Sadaka","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"R18-20250605","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.4103\/ijo.IJO_1788_21","article-title":"Safety and efficacy of suprachoroidal triamcinolone acetonide for the management of serous choroidal detachment prior to rhegmatogenous retinal detachment surgery: a Pilot study","volume":"70","author":"Kohli","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"R19-20250605","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/IAE.0b013e3182923463","article-title":"Vitrectomy combined with periocular\/intravitreal injection of steroids for rhegmatogenous retinal detachment associated with choroidal detachment","volume":"34","author":"Wei","year":"2014","journal-title":"Retina"},{"key":"R20-20250605","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s004170100345","article-title":"Primary vitrectomy for the management of rhegmatogenous retinal detachment associated with choroidal detachment","volume":"239","author":"Ghoraba","year":"2001","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R21-20250605","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1350-9462(01)00023-4","article-title":"Proliferative vitreoretinopathy: risk factors and pathobiology","volume":"21","author":"Pastor","year":"2002","journal-title":"Prog Retin Eye Res"},{"key":"R22-20250605","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ajo.2007.10.015","article-title":"Retinal redetachment after silicone oil removal in proliferative vitreoretinopathy: a prognostic factor analysis","volume":"145","author":"Lam","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R23-20250605","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/IIO.0000000000000258","article-title":"Proliferative vitreoretinopathy: a review","volume":"59","author":"Idrees","year":"2019","journal-title":"Int Ophthalmol Clin"},{"key":"R24-20250605","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1167\/iovs.16-20912","article-title":"Effect of methotrexate on an in vitro patient-derived model of proliferative vitreoretinopathy","volume":"58","author":"Amarnani","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R25-20250605","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/24741264221135799","article-title":"Intraocular methotrexate for the treatment and prevention of proliferative vitreoretinopathy: a review","volume":"7","author":"McAllister","year":"2023","journal-title":"J Vitreoretin Dis"},{"key":"R26-20250605","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3928\/23258160-20230220-01","article-title":"Low-dose intravitreal methotrexate for proliferative vitreoretinopathy","volume":"54","author":"Ullah","year":"2023","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"R27-20250605","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3928\/23258160-20220920-04","article-title":"Intravitreal methotrexate for the prevention and treatment of proliferative vitreoretinopathy in rhegmatogenous retinal detachment: a systematic review","volume":"53","author":"Balas","year":"2022","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"R28-20250605","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1001\/archopht.119.10.1518","article-title":"Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma","volume":"119","author":"Velez","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"R29-20250605","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/ICO.0000000000002774","article-title":"Corneal toxicity of intravitreal methotrexate used for the treatment of proliferative vitreoretinopathy in silicone oil-filled eyes: a case series","volume":"41","author":"Shen-Sampas","year":"2022","journal-title":"Cornea"},{"key":"R30-20250605","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.3390\/jcm9082672","article-title":"Corneal epithelial toxicity after intravitreal methotrexate injection for vitreoretinal lymphoma: clinical and in vitro studies","volume":"9","author":"Jeong","year":"2020","journal-title":"J Clin Med"},{"key":"R31-20250605","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0002-9394(99)00201-9","article-title":"Timing of retinal redetachment after removal of intraocular silicone oil tamponade","volume":"128","author":"Jonas","year":"1999","journal-title":"Am J Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T17:01:48Z","timestamp":1749142908000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004046"}},"subtitle":["A Pilot Study"],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004046","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]}}}